- CA$35.89m
- CA$35.55m
- CA$8.29m
Annual balance sheet for MustGrow Biologics, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 9.62 | 7.02 | 6.82 | 3 | 0.919 |
| Net Total Receivables | 0.064 | 0.088 | 0.095 | 0.103 | 0.069 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 9.7 | 7.13 | 6.94 | 4.66 | 3.06 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | — | — | — | 0.18 | 0.033 |
| Net Intangible Assets | |||||
| Total Assets | 9.7 | 7.13 | 6.94 | 5.42 | 3.09 |
| Payable / Accrued | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.863 | 1.54 | 1.21 | 2.9 | 2.07 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 1.25 | 1.9 | 1.35 | 3.25 | 2.23 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 8.46 | 5.24 | 5.58 | 2.17 | 0.867 |
| Total Liabilities & Shareholders' Equity | 9.7 | 7.13 | 6.94 | 5.42 | 3.09 |
| Total Common Shares Outstanding |